FEATURE ARTICLES

Janssen Immunology — Science & Market Drivers
Janssen Immunology — Science & Market Drivers

In this exclusive with Sue Dillon, Ph.D., head of Janssen Immunology, she talks candidly about topics such as how the company marries the precommercial and commercial functions.

More featured articles

ALSO IN THIS MONTH'S ISSUE

More from Life Science Leader

WEB-EXCLUSIVE EDITORIAL

  • Why Pharma Is Seeking A New Type Of BD Leader
    Why Pharma Is Seeking A New Type Of BD Leader

    Early last year I had a call with the Global Head of Business Development and APAC (Asia Pacific) Regional Head of Human Resources at a major biotech group. Once initial pleasantries were exchanged the first words from this executive were “Rob, we’re looking to hire a scout ASAP to lead business development in Asia.”

  • Mobile Apps: A Look At Their Use In The Precommercial Phase
    Mobile Apps: A Look At Their Use In The Precommercial Phase

    In the precommercial phase, companies invest significant time and money to recruit patients and collect real-world data as well as uncover gaps in current therapies and emerging or anticipated public health needs. That’s why pharmaceutical companies are proactively evaluating and deploying mobile apps to accomplish these goals more quickly, efficiently, and effectively.  You can ping someone and get their attention immediately – faster than eliciting a response from an email. This type of engagement is also more conducive to a variety of lifestyles than any other medium.

  • A Prescription For Change: Navigating Tax Reform In 2017

    Proposed changes to the tax code could have a pervasive impact on Pharma’s business strategy.

  • Preparing For IDMP Compliance – What You Need to Know

    Beginning in early 2017, life sciences organizations that intend to manufacture and/or market medicinal products within the European Union will be required to comply with the Identification of Medicinal Products (IDMP) regulations, a global framework for identifying medicinal products, set forth by the European Medicines Agency (EMA).

  • Trump/GOP Plans For Obamacare, Medicare, & Medicaid Have Far-Reaching Pharma Effects
    Trump/GOP Plans For Obamacare, Medicare, & Medicaid Have Far-Reaching Pharma Effects

    An ideology-driven rush to undo decades of healthcare policy — and the uncertainty this will create — presents real hazards for every segment of the U.S. healthcare system, including the pharmaceutical industry.

More web-exclusive editorial

CUTTING ROOM FLOOR EDITORIAL

More cutting room floor editorial

DECEMBER 2016 DIGITAL EDITION

BLOGS

  • Despite Delays, JPM 2017 Still Pays Off For Me
    Despite Delays, JPM 2017 Still Pays Off For Me

    For the second year in a row my travel plans to the biopharmaceutical industry’s yearly kickoff event — the 35th Annual J. P. Morgan Healthcare Conference in San Francisco —was disrupted by weather. And though I once again arrived a day late, there was still plenty to keep me busy during JPM. For example, I still had the opportunity to sit in breakout Q&A sessions involving Alkermes, BMS, Chimerix, GSK, Mylan NV, and Shire. I witnessed company presentations that included AbbVie, CSL Limited, and IDEXX (just to name a few). I attended keynotes involving the Vice President of the United States, Joe Biden, who provided an update on the Cancer Moonshot initiative. I heard political consultants Karl Rove and James Carville debate the pros and cons of repealing and replacing the Affordable Care Act. I even had the opportunity to hear Juan Enriquez, co-author of Evolving Ourselves, share his insights on the next species of human. And while this may seem like a lot, it really only scratches the surface as to the amount of activity that takes place during JPM in January.

  • Night Of Light: California Life Science Association (CLSA)
    Night Of Light: California Life Science Association (CLSA)

    Because I live only a day-trip away from San Francisco, it is convenient for me to travel there for industry events — a trek always accompanied by reflective reveries for the hometown of my film-student days. So, for the third time since June, and with another week scheduled for early January, I am once again city-bound, leaving home mid-day and getting into my hotel in plenty of time to make the 5:30 PM reception for the annual Pantheon Awards dinner, held by the California Life Science Association (CLSA).

More blogs

@LIFESCILEADER1

2016 CRO AWARDS SPECIAL EDITION

2016 CMO AWARDS SPECIAL EDITION

 UPCOMING EVENTS

The Investigational New Drug (IND) Submission - Tips to Win the First Time January 25, 2017
1pm-2:30pm EST, Online Training
Price:  $299 - Includes Bonus Handouts!
Data Integrity - Detecting & Mitigating Risk January 26, 2017
1pm-2:30pm EST, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Understanding & Implementing The New NIH & FDA Draft Clinical Trial Protocol Template January 30, 2017
1pm-2:30pm EST, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Temperature Controlled Logistics 2017 January 30, 2017 - February 2, 2017
ExCeL Centre, London, United Kingdom
Immuno-Oncology 360° February 1 - 3, 2017
The Roosevelt Hotel, New York, NY
More events